Skip to main content
Current Enzyme Inhibition aims to publish all the latest and outstanding developments in enzyme inhibition studies with regards to the mechanisms of inhibitory processes of enzymes, recognition of active sites, and the discovery of agonists and antagonists, leading to the design and development of new drugs of significant therapeutic value. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a range of enzymes that can be exploited for drug development. Current Enzyme Inhibition is an essential journal for every pharmaceutical and medicinal chemist who wishes to have up-to-date knowledge about each and every development in the study of enzyme inhibition.

Publisher: Bentham Science Publishers

More about this publication?
Volume 5, Number 2, 2009

Articles

Post-Wortmannin Era: Novel Phosphoinositide 3-Kinase Inhibitors with Potential Therapeutic Applications
pp. 66-86(21)
Authors: Braccini, Laura; Morello, Fulvio; Perino, Alessia; Hirsch, Emilio

Favourites:
ADD

Engineered Protein Protease Inhibitors
pp. 87-98(12)
Authors: Viswanathan, Malini; Comeau, Stephen R.; Ladner, Robert C.

Favourites:
ADD

Poly(ADP-Ribosylation): Beneficial Effects of Its Inhibition
pp. 99-109(11)
Authors: Giansanti, V.; Dona, F.; Scovassi, A. I.

Favourites:
ADD

Serine Protease Inhibitor Kazal Type 1 (SPINK1): Beyond the Trypsin Inhibitor
pp. 110-116(7)
Authors: Ohmuraya, Masaki; Ozaki, Nobuyuki; Hirota, Masahiko; Baba, Hideo; Yamamura, Ken-ichi

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content